e-learning
resources
Glasgow 2004
Sunday 05.09.2004
Clinical aspects of OSA
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Underperfusion of temporal poli: a marker of cognitive impairment in obstructive sleep apnea but not in COPD
R. Antonelli Incalzi, M. L. Calcagni, C. Marra, A. Petrone, D. Selvaggio, M. Andreani, A. Gaballo, A. Gemma, A. Giordano, F. Mormile (Rome, Italy)
Source:
Annual Congress 2004 - Clinical aspects of OSA
Session:
Clinical aspects of OSA
Session type:
Thematic Poster Session
Number:
789
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Antonelli Incalzi, M. L. Calcagni, C. Marra, A. Petrone, D. Selvaggio, M. Andreani, A. Gaballo, A. Gemma, A. Giordano, F. Mormile (Rome, Italy). Underperfusion of temporal poli: a marker of cognitive impairment in obstructive sleep apnea but not in COPD. Eur Respir J 2004; 24: Suppl. 48, 789
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Imaging of complicated pneumonia: what is new?
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Impairment of vigilance during different cognitive processes in obstructive sleep apnea (OSA) patients
Source: Eur Respir J 2002; 20: Suppl. 38, 494s
Year: 2002
Effect of obstructive sleep apnea syndrome (OSAS) on cognitive performances
Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing
Year: 2009
Functional and clinical correlates of cognitive impairment in obstructive sleep apnoea syndrome
Source: Eur Respir J 2001; 18: Suppl. 33, 254s
Year: 2001
IQ score and cognitive function in obstructive sleep apnoea patients
Source: Eur Respir J 2003; 22: Suppl. 45, 92s
Year: 2003
The effect of concomitant COPD on obstructive sleep apnea syndrome severity and sleep structure
Source: Annual Congress 2011 - Obstructive sleep apnoea as a comorbidity
Year: 2011
Metabolic disturbances in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) patients
Source: Annual Congress 2010 - Clinical aspects of sleep apnoea
Year: 2010
Association between obstructive sleep apnoea (OSA) severity and metabolic disturbances
Source: International Congress 2017 – Obstructive and central sleep apnoea: consequences and comorbidities
Year: 2017
Predictors of hypercapnia in obstructive sleep apnoea (OSA)
Source: Annual Congress 2010 - Lung disease and mountain sickness: the importance of ventilatory control
Year: 2010
Evaluation of the executive functions of the brain in adult patients with obstructive sleep apnea syndrome
Source: Virtual Congress 2020 – From pathophysiology to clinical consequences of sleep and breathing disorders
Year: 2020
Neuropsychological functioning after CPAP treatment in obstructive sleep apnea: A meta-analysis
Source: Annual Congress 2012 - Current trends in home mechanical ventilation
Year: 2012
Comparison of plasma NT-proBNP level in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA)
Source: Annual Congress 2008 - Control of breathing and respiratory disorders during sleep
Year: 2008
NT-proBNP in obstructive sleep apnoea (OSA)
Source: Eur Respir J 2006; 28: Suppl. 50, 415s
Year: 2006
Most obstructive sleep apnoea patients exhibit vigilance and attention deficits on an extended battery of tests
Source: Eur Respir J 2005; 25: 75-80
Year: 2005
Impaired work productivity in obstructive sleep apnea patients
Source: Annual Congress 2010 - Sleep disorders: neurology, smoking and daytime sleepiness
Year: 2010
Prevalence of stroke in obstructive sleep apnoea (OSA) patients
Source: Eur Respir J 2007; 30: Suppl. 51, 331s
Year: 2007
Obstructive sleep apnoea: the effect of intermittent hypoxia on cognitive function
Source: ERS Conference
Year: 2015
Does personality change in obstructive sleep apnea (OSA) patients using CPAP?
Source: Eur Respir J 2006; 28: Suppl. 50, 409s
Year: 2006
Working memory in obstructive sleep apnea (OSA) patients: a functional MRI study
Source: Annual Congress 2008 - Assessment of sleep apnoea
Year: 2008
Cardiohemodynamics parameters in patients with COPD and obstructive sleep apnea, (OSA).
Source: International Congress 2017 – Pathophysiological aspects of comorbid conditions in obstructive sleep apnoea
Year: 2017
Degree of sleepiness and cardiac alterations in non-hypertensive obstructive sleep apnea (OSA) patients
Source: Annual Congress 2009 - Cardiovascular complications in obstructive sleep apnoea
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept